Oncology & Cancer

New immunotherapy drug effective for melanoma, other cancers

A new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients, a breakthrough that could extend to the treatment of other cancers. Relatlimab is the first immunotherapy treatment ...

Genetics

Study encourages cautious approach to CRISPR therapeutics

A comprehensive study—conducted by researchers at Sanford Burnham Prebys, the National Cancer Institute (NCI) and other groups—has shown that gene editing, specifically gene knockout (KO), with CRISPR -Cas9 can favor ...

Oncology & Cancer

Discovery could lead to better cancer immunotherapy

A type of white blood cell previously known only as a helper in the immune system appears also to be the instigator of the body's defenses against cancerous tumors. The discovery could lead to more effective cancer immunotherapy, ...

Medical research

How curiosity sparked pioneering cancer research

"I did this research by chance. I was enrolled at the Koch Institute for Integrative Cancer Research at MIT for my postdoctoral work to develop electrical devices with biotechnology. The institute is focused on cancer research ...

Oncology & Cancer

Anti-cancer inhibitor could have dual effect

TG2, an enzyme known to help cancers spread more quickly, also plays a role in regulating T-cells, according to a Northwestern Medicine study published in the Journal for ImmunoTherapy of Cancer.

page 12 from 40